STOKE THERAPEUTICS INC shareholders Q2 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.

STOKE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SIGNATUREFD, LLC 1,031$10,9600.00%
Endurance Wealth Management, Inc. 300$20.00%
Daiwa Securities Group Inc. 126$10.00%
SIMPLEX TRADING, LLC 50,555$5370.00%
EverSource Wealth Advisors, LLC 127$1,3500.00%
Lindbrook Capital, LLC 412$4,3800.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.